Literature DB >> 51933

Biochemical properties of the bromodeoxyuridine-induced guinea pig virus.

R Michalides, J Schlom, J Dahlberg, K Perk.   

Abstract

The biophysical and biochemical properties of the virus particles released by guinea pig embryo cells treated with 5-bromo-2'-deoxyuridine (BUdR) have been compared to those of the B-type mouse mammary tumor virus (MMTV) and the C-type Rauscher murine leukemia virus. The high-molecular-weight (60 to 70S) RNA of the BUdR-induced guinea pig virus (GPV) has a molecular weight of 8 X 106 when measred by mixed agarose polyacylamide gel electrophoresis. The virus particles isolated from the tissue culture medium of BUdR-induced guniea pig cells have the following properties in common with MMTV: (i) a buoyant density of 1.18 g/ml in sucrose and 1.21 g/ml in CsCl, and (ii) a DNA polymerase that prefers Mg2+ over Mn2+ in an assay using the synthetic template poly(rC):oligo(dG). No nucleic acid sequence homology between GPV RNA and the viral RNAs of the MMTV, murine leukemia virus, hamster sarcoma virus, or Mason-Pfizer monkey virus could be observed in a competition hybridization assay using the radioactive-labeled GPV 60 to 70S RNA. By this same competition by hybridization assay the frequency of GPV proviral sequences was estimated to be at least 83 per haploid cellular genome of guniea pig cells. No nucleic acid sequences related to be GPV RNA were detected in the DNA of normal tissues of mice, rats, cats, dogs, baboons, or humans by direct RNA-DNA hybridization using radioactive GPV60 to 70S RNA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51933      PMCID: PMC354766     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  The detection and study of tumor viruses with the electron microscope.

Authors:  W BERNHARD
Journal:  Cancer Res       Date:  1960-06       Impact factor: 12.701

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  RNA-directed DNA polymerase--properties and functions in oncogenic RNA viruses and cells.

Authors:  M Green; G F Gerard
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1974

4.  Comparative biochemical properties of RNA-directed DNA polymerases from Rauscher murine leukemia virus and avian myeloblastosis virus.

Authors:  L C Waters; W K Yang
Journal:  Cancer Res       Date:  1974-10       Impact factor: 12.701

5.  Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus.

Authors:  D M Livingston; G J Todaro
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

6.  Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.

Authors:  M V Nermut; H Frank; W Schäfer
Journal:  Virology       Date:  1972-08       Impact factor: 3.616

7.  Infectivity of cell cultures by a virus isolated from a mammary carcinoma of a rhesus monkey.

Authors:  H C Chopra; I Zelljadt; E M Jensen; M M Mason; N J Woodside
Journal:  J Natl Cancer Inst       Date:  1971-01       Impact factor: 13.506

8.  RNA subunit structure of Mason-Pfizer monkey virus.

Authors:  G Schochetman; J Schlom
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

9.  Characterization and separation of viral DNA polymerase in mouse milk.

Authors:  R S Howk; L A Rye; L A Killeen; E M Scolnick; W P Parks
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Induction of type C viruses in cultured guinea pig cells.

Authors:  D P Nayak; P R Murray
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

View more
  18 in total

1.  Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus.

Authors:  R H Schloemer; J Schlom; G Schochetman; P Kimball; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

2.  Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro.

Authors:  D K Howard; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

3.  Mason-Pfizer virus RNA genome: relationship to the RNA of morphologically similar isolates and other oncornaviruses.

Authors:  D Colcher; W Drohan
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

4.  Quantitative measurement of intracellular RNA genomes of Rauscher murine leukemia virus by competition hybridization in DNA excess.

Authors:  J L East; J C Chan; R J Bartlett; J E Knesek
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Equine infectious anemia virus: evidence favoring classification as a retravirus.

Authors:  H P Charman; S Bladen; R V Gilden; L Coggins
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

6.  Expression of endogenous retroviral genes in leukemic guinea pig cells.

Authors:  A R Davis; D P Nayak
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

Review 7.  Viruses of guinea pigs: considerations for biomedical research.

Authors:  G D Hsiung; F J Bia; C K Fong
Journal:  Microbiol Rev       Date:  1980-09

8.  Characterization of conditions for the activation of endogenous guinea pig retrovirus in cultured cells by 5-bromo-2'-deoxyuridine.

Authors:  M B Lerner-Tung; S L Doong; Y C Cheng; G D Hsiung
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

9.  Characterization of the oncornavirus particles in the plasma of guinea pigs with L2C leukemia.

Authors:  R Michalides; J Scholom; J Pearson; K Perk; J Dahlberg
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

10.  Mason-Pfizer like virus in kidney grafted patients.

Authors:  L Thiry; S Sprecher-Goldberger; P Vandenbussche; M Bossens; P Vereerstraten; O Hestermans-Medard
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.